Details for New Drug Application (NDA): 077450
✉ Email this page to a colleague
The generic ingredient in OCTREOTIDE ACETATE is octreotide acetate. There are twenty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.
Summary for 077450
| Tradename: | OCTREOTIDE ACETATE |
| Applicant: | Fresenius Kabi Usa |
| Ingredient: | octreotide acetate |
| Patents: | 0 |
Pharmacology for NDA: 077450
| Mechanism of Action | Somatostatin Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 077450
Suppliers and Packaging for NDA: 077450
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OCTREOTIDE ACETATE | octreotide acetate | INJECTABLE;INJECTION | 077450 | ANDA | Fresenius Kabi USA, LLC | 63323-378 | 63323-378-05 | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-378-05) / 5 mL in 1 VIAL, MULTI-DOSE |
| OCTREOTIDE ACETATE | octreotide acetate | INJECTABLE;INJECTION | 077450 | ANDA | Fresenius Kabi USA, LLC | 63323-379 | 63323-379-05 | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-379-05) / 5 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.2MG BASE/ML | ||||
| Approval Date: | Feb 10, 2006 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1MG BASE/ML | ||||
| Approval Date: | Feb 10, 2006 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
